OBJECTIVES: To investigate whether there are any variations in chondrocyte susceptibility to an apoptotic stimulus between cells of articular cartilage (AC) from equine joints that differ in prevalence of osteoarthritis (OA). METHODS: Cartilage from macroscopically normal equine metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) joints was used. Prior to culture, chondrocyte viability was assessed using the fluorescein diacetate (FDA) and propidium iodide paravital staining method. AC explants were subsequently treated with tumour necrosis factor-α (TNF-α) in combination with Actinomycin D to induce apoptosis. Apoptosis of chondrocytes in cartilage sections was assessed by expression of active caspase-3 using indirect immunohistochemistry and sections also histologically graded using a 'modified' Mankin scoring system. RESULTS: Prior to culture (mean ± standard deviation) chondrocyte viability was 80.7% (3.5). The extent of chondrocyte apoptosis induced by TNF-α/Actinomycin D varied markedly according to the joint type that the cartilage was sampled from. For MCP joints, the extent of overall chondrocyte apoptosis was significantly higher (P < 0.001) in stimulated explants (26.7%, 10.3) than that observed in unstimulated control samples (9.6%, 7.5). Conversely, chondrocytes from PIP and DIP joint cartilage did not respond significantly to apoptotic stimulation (P > 0.05). Significant variations in cellularity and thickness were also evident between cartilages of different joint types. CONCLUSIONS: Data in this study demonstrate that chondrocytes from three equine joint types with varying prevalences of OA differ significantly in terms of susceptibility to apoptosis induction. This may provide a possible explanation for the joint-specific nature of the disease.
OBJECTIVES: To investigate whether there are any variations in chondrocyte susceptibility to an apoptotic stimulus between cells of articular cartilage (AC) from equine joints that differ in prevalence of osteoarthritis (OA). METHODS:Cartilage from macroscopically normal equine metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) joints was used. Prior to culture, chondrocyte viability was assessed using the fluorescein diacetate (FDA) and propidium iodide paravital staining method. AC explants were subsequently treated with tumour necrosis factor-α (TNF-α) in combination with Actinomycin D to induce apoptosis. Apoptosis of chondrocytes in cartilage sections was assessed by expression of active caspase-3 using indirect immunohistochemistry and sections also histologically graded using a 'modified' Mankin scoring system. RESULTS: Prior to culture (mean ± standard deviation) chondrocyte viability was 80.7% (3.5). The extent of chondrocyte apoptosis induced by TNF-α/Actinomycin D varied markedly according to the joint type that the cartilage was sampled from. For MCP joints, the extent of overall chondrocyte apoptosis was significantly higher (P < 0.001) in stimulated explants (26.7%, 10.3) than that observed in unstimulated control samples (9.6%, 7.5). Conversely, chondrocytes from PIP and DIP joint cartilage did not respond significantly to apoptotic stimulation (P > 0.05). Significant variations in cellularity and thickness were also evident between cartilages of different joint types. CONCLUSIONS: Data in this study demonstrate that chondrocytes from three equine joint types with varying prevalences of OA differ significantly in terms of susceptibility to apoptosis induction. This may provide a possible explanation for the joint-specific nature of the disease.
Authors: Wolfgang Eger; Barbara L Schumacher; Jürgen Mollenhauer; Klaus E Kuettner; Ada A Cole Journal: J Orthop Res Date: 2002-05 Impact factor: 3.494
Authors: M J López-Armada; B Caramés; M Lires-Deán; B Cillero-Pastor; C Ruiz-Romero; F Galdo; F J Blanco Journal: Osteoarthritis Cartilage Date: 2006-02-21 Impact factor: 6.576
Authors: Shi Sirong; Chen Yang; Tian Taoran; Li Songhang; Lin Shiyu; Zhang Yuxin; Shao Xiaoru; Zhang Tao; Lin Yunfeng; Cai Xiaoxiao Journal: Bone Res Date: 2020-02-10 Impact factor: 13.567
Authors: Bridget Fox; Jan-Thorsten Schantz; Richard Haigh; Mark E Wood; Phillip K Moore; Nick Viner; Jeremy P E Spencer; Paul G Winyard; Matthew Whiteman Journal: J Cell Mol Med Date: 2012-04 Impact factor: 5.310
Authors: Shi Sirong; Chen Yang; Tian Taoran; Li Songhang; Lin Shiyu; Zhang Yuxin; Shao Xiaoru; Zhang Tao; Lin Yunfeng; Cai Xiaoxiao Journal: Bone Res Date: 2020-02-10 Impact factor: 13.567